about
Developing a prototype system for integrating pharmacogenomics findings into clinical practiceUsability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approach.Cost-effectiveness of a computerized provider order entry system in improving medication safety ambulatory care.Preparing Electronic Clinical Data for Quality Improvement and Comparative Effectiveness Research: The SCOAP CERTAIN Automation and Validation ProjectAchieving and sustaining automated health data linkages for learning systems: barriers and solutions.Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysisElectronic prescribing at the point of care: a time-motion study in the primary care setting.Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).Prescriber and staff perceptions of an electronic prescribing system in primary care: a qualitative assessment.A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network.Systematic review of comparative effectiveness data for oncology orphan drugs.The impact of computerized provider order entry on medication errors in a multispecialty group practice.Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis: A Bayesian Network Meta-analysis.Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons.Effect of age on international normalized ratio at the time of major bleeding in patients treated with warfarin.Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin.Deriving rules and assertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions.A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults.The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time motion study.Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians.Effect of switching medically vulnerable patients with uncontrolled diabetes from isophane insulin human to insulin glargine.Characterization of prescribing errors in an internal medicine clinic.Health-related quality of life assessment in chronic kidney disease.A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia.Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding.Applying quantitative benefit-risk analysis to aid regulatory decision making in diagnostic imaging: methods, challenges, and opportunities.Communication Training, Adverse Events, and Quality Measures: 2 Retrospective Database Analyses in Washington State Hospitals.Characterizing Health Care Utilization, Direct Costs, and Comorbidities Associated with Interstitial Cystitis: A Retrospective Claims Analysis.Impact of traveling to visit friends and relatives on chronic disease management.Postoperative acquired coagulopathy: a pilot study to determine the impact on clinical and economic outcomes.
P50
Q28533569-D2F3DB29-17B1-40EC-8802-9B7FCED0173FQ28540676-B65C9F10-0967-434D-822B-04DD39D5AFEBQ30582516-753273C7-0106-4910-B74D-9F79AA1FBCFEQ30925100-79CD39C6-2B9B-4973-A5FA-393EB05B8089Q30925449-236376D7-1832-43C1-9465-377EDDE0B45FQ33605478-A8568726-8BFF-4338-997B-9BFA3BB7F692Q33618755-B9A34E99-CC4C-41B8-9D06-D9AC9E740179Q33658763-72862DC5-DBCC-4421-A1F5-F9621AF5ADA6Q33750790-BA442456-0722-40BB-A28C-CD551658DD29Q33901024-235DC7AF-2186-470D-B47F-58BE12436DD9Q34204588-6A0E27CB-20D3-4E79-B52D-B23824ECC2EEQ34371523-E172AB3E-460F-4BA4-9B95-BF2D48B7AED9Q34446260-4D319B63-103F-430D-B266-15556287DAF9Q34732285-27486B9C-86F8-4AF3-AB38-0CB7ED8FE715Q35783707-01B41EA7-186F-4413-A97C-36408F753667Q35997998-F2726F39-3E78-49F9-9E6D-970996863E21Q36175128-5FA13C36-B546-4BDD-BBAA-1E27FAF66B87Q36253538-77B29982-EC93-4829-93B6-991AE7C80DD7Q36404533-66ECFD29-DDF9-4161-B0BB-2C6FEE1D822CQ36438790-3B75ED9F-1BC4-422C-B77C-31C44F48595EQ36600818-16B9BDBE-A589-4559-B27F-A862B74F3ADFQ36818099-56AE0329-3DFB-4C01-86C4-BE866A7966D2Q37609332-9D84F9BC-C565-4B24-B303-4A886A21EBB8Q37992355-8E404C80-6933-46AB-AEF8-F9BFCCD5E0DCQ38066159-D03D71FC-F734-4D9C-8830-CF5E2E032356Q38238358-69E62848-A29C-42FA-8D16-684246188BB0Q38696708-F8900F33-39CD-42DE-9BA8-F5385C15A5B5Q38874613-9AAC34FD-0E0B-4931-A09E-E469074BC206Q42272381-04D2051E-82E0-4595-82D3-A4745EEB1DF5Q45725988-5F5DCFCB-DCC3-485A-8BA2-5FB28C50AD0A
P50
description
onderzoeker
@nl
name
Emily Beth Devine
@ast
Emily Beth Devine
@en
Emily Beth Devine
@es
Emily Beth Devine
@nl
Emily Beth Devine
@sl
type
label
Emily Beth Devine
@ast
Emily Beth Devine
@en
Emily Beth Devine
@es
Emily Beth Devine
@nl
Emily Beth Devine
@sl
prefLabel
Emily Beth Devine
@ast
Emily Beth Devine
@en
Emily Beth Devine
@es
Emily Beth Devine
@nl
Emily Beth Devine
@sl